PAPER
Hydroxylation of Ring A of Flavan-3-ols
3257
Yield: 35 mg (34%); colourless oil; Rf 0.53 (EtOAc–cyclohexane,
3:7).
1H NMR: d = 7.02–6.97 (m, 2 H, H-2¢, H-6¢), 6.90 (d, J = 8.0 Hz, 1
H, H-5¢), 6.32 (s, 1 H, H-8), 4.42 (d, J = 8.1 Hz, 1 H, H-2), 4.06 (m,
1 H, H-3), 3.90 (s, 3 H, CH3O), 3.89 (s, 3 H, CH3O), 3.88 (s, 3 H,
CH3O), 3.82 (s, 3 H, CH3O), 3.17 (dd, J = 16.5, 5.7 Hz, 1 H, H-4),
2.72 (dd, J = 16.5, 9.0 Hz, 1 H, H-4).
13C NMR: d = 149.67 (C), 149.64 (C), 147.23 (C), 146.91 (C),
133.00 (C), 130.49 (C), 120.15 (C-6¢), 111.57 (C-5¢), 110.30 (C-2¢),
106.59 (C-4a), 95.73 (C-8), 81.93 (C-2), 68.43 (C-3), 60.37
(CH3O), 56.29 (CH3O), 56.14 (2 × CH3O), 56.10 (CH3O), 28.26 (C-
4).
IR: 3521, 3062, 3031, 2920, 2853, 1735, 1606, 1512, 1453, 1223
cm–1.
1H NMR: d = 7.43–7.21 (m, 23 H), 7.11–7.03 (m, 2 H), 6.94 (d,
J = 1.5 Hz, 1 H, H-2¢), 6.92 (d, J = 8.1, Hz, 1 H, H-5¢), 6.92 (dd,
J = 8.1, 1.5 Hz, 1 H, H-6¢), 5.20–4.89 (m, 10 H), 4.79 (d, J = 7.8 Hz,
1 H, H-2), 4.23, 4.12 (AB, J = 12 Hz, 2 H), 3.62 (m, 1 H, H-3), 2.90
(dd, J = 16.5, 5.1 Hz, 1 H, H-4), 2.70 (dd, J = 16.5, 8.1 Hz, 1 H, H-
4), 1.94 (s, 3 H).
13C NMR: d = 171.00 (CO), 149.03 (2 × C), 146.52 (C), 145.42 (C),
145.12 (C), 138.03 (C), 137.46 (C), 137.35 (C), 137.27 (C), 137.03
(C), 136.26 (C), 132.60 (C), 128.82–127.46 (Bn-CH), 120.23 (C-
6¢), 115.18 (C-2¢), 114.11 (C-5¢), 112.18 (C), 110.71 (C), 79.68 (C-
2), 76.72 (CH2), 74.99 (CH2), 74.51 (C-3), 71.73 (CH2), 71.61
(CH2), 70.48 (CH2), 56.91 (CH2OAc), 26.60 (C-4), 21.14 (CH3CO).
MS (ESI): m/z (%) = 363 (M + H+, 100), 193 (10), 183 (50), 151
(15).
p-Benzoquinone (16)
Traces of 16 were obtained by treating 6b with DMDO followed by
purification by preparative TLC.
Yellow oil; Rf 0.25 (EtOAc–cyclohexane, 3:7).
+
MS (ESI): m/z (%) = 846 (M + NH4 , 100), 829 (M + H+, 80).
IR: 3064, 3031, 2924, 2869, 1690, 1648, 1628, 1513, 1453, 1124
cm–1.
1H NMR: d = 7.45–7.27 (m, 18 H), 7.13–7.11 (m, 2 H), 6.90 (d,
J = 8.0 Hz, 1 H, H-5¢), 6.77–6.73 (m, 2 H, H-2¢, H-6¢), 5.86 (s, 1 H,
H-6), 5.18–5.06 (m, 7 H), 4.38, 4.29 (AB, J = 12.0 Hz, 2 H), 3.72
(m, 1 H, H-3), 2.60–2.40 (m, 2 H, H-4).
(2R,3S)-8-Bromo-3,6-dihydroxy-5,7,3¢,4¢-tetra-O-benzylflavan
(13b)
Prepared from 13a by the typical procedure, but with a reaction tem-
perature of –40 °C.
Yield: 37 mg (36%); colourless oil; Rf 0.21 (EtOAc–cyclohexane,
13C NMR: d = 186.23 (C), 175.77 (C), 156.02 (C), 151.34 (C),
149.40 (C), 149.11 (C), 137.50 (C), 137.23 (C), 137.18 (C), 134.38
(C), 130.52 (C), 128.99–127.43 (Bn-CH), 119.81 (C-6¢), 116.66
(C), 115.29 (C-5¢), 113.74 (C-2¢), 108.49 (C-6), 80.51 (C-2), 72.60
(C-3), 71.55 (3 × CH2), 71.23 (CH2), 23.20 (C-4).
3:7).
IR: 3515, 3087, 3064, 3031, 2921, 1605, 1512, 1453 cm–1.
1H NMR: d = 7.52–7.28 (m, 25 H), 7.00 (br s, 1 H, H-2¢), 6.94–6.87
(m, 2 H, H-5¢, H-6¢), 5.23–4.94 (m, 8 H), 4.72 (d, J = 6.9 Hz, 1 H,
H-2), 4.67 (s, 1 H, OH), 4.00–3.87 (m, 1 H, H-3), 2.91 (dd, J = 16.5,
4.5 Hz, 1 H, H-4), 2.61 (dd, J = 16.5, 7.8 Hz, 1 H, H-4).
MS (CI, NH3): m/z (%) = 682 (M+· +NH4 , 100), 665 (MH+·, 50).
+
13C NMR: d = 149.39 (C), 149.20 (C), 144.11 (C), 143.45 (2 × C),
137.34 (2 × C), 137.16 (2 × C), 136.74 (C), 130.92 (C), 128.86–
127.09 (Bn-CH), 120.03 (C-6¢), 115.19 (C-2¢), 113.76 (C-5¢),
111.81 (C), 100.31 (C), 81.52 (C-2), 75.80 (CH2), 74.67 (CH2),
71.48 (2 × CH2), 67.81 (C-3), 28.08 (C-4).
o-Benzoquinone (17)
Traces of 17 were obtained by treating 6b with DMDO followed by
purification by preparative TLC.
Deep red oil; Rf 0.11 (EtOAc–cyclohexane, 3:7).
IR: 3064, 3030, 2926, 2870, 1648, 1633, 1580, 1453, 1160 cm–1.
MS (ESI): m/z (%) = 764 (100), 762 (90), 747 (50), 745 (M + H+,
1H NMR: d = 7.45–7.25 (m, 18 H), 7.10–7.06 (m, 2 H), 6.79 (d,
J = 2.0 Hz, 1 H, H-5¢), 6.77–6.75 (m, 2 H, H-2¢, H-6¢), 5.80 (s, 1 H,
H-6), 5.21–4.99 (m, 7 H), 4.40, 4.25 (AB, J = 12.0 Hz, 2 H), 3.71–
3.64 (m, 1 H, H-3), 2.62–2.48 (m, 2 H, H-4).
13C NMR: d = 175.69 (C), 165.28 (C), 151.94 (C), 149.62 (C),
149.17 (C), 141.05 (C), 137.46 (C), 137.12 (C), 134.55 (C), 130.13
(C), 128.99–127.11 (Bn-CH), 120.14 (C-6¢), 115.12 (C-5¢), 113.83
(C-2¢), 107.95 (C-8), 105.77 (C-4a), 82.43 (C-2), 72.70 (C-3), 71.64
(CH2), 71.53 (CH2), 71.40 (CH2), 71.02 (CH2), 22.51 (C-4).
45), (729 (20), 727 (25).
(2R,3S)-3-Acetoxy-5,7,3¢,4¢-tetra-O-benzyl-8-formyl-6-
hydroxyflavan (15b)
Prepared from 15a by the typical procedure, but with a reaction tem-
perature of –40 °C.
Yield: 220 mg (35%); colourless oil; Rf 0.26 (EtOAc–cyclohexane,
3:7).
1H NMR: d = 10.43 (s, 1 H, CHO), 7.42–7.31 (m, 20 H), 6.91–6.89
(m, 2 H, H-2¢, H-5¢), 6.80 (dd, J = 8.5, 1.5 Hz, 1 H, H-6¢), 5.58 (s, 1
H, OH), 5.28–5.05 (m, 10 H), 2.70–2.64 (m, 2 H, H-4).
13C NMR: d = 187.94 (CHO), 170.08 (CO), 150.46 (C), 149.31 (C),
149.19 (C), 149.02 (C), 145.93 (C), 137.23 (C), 137.07 (C), 136.95
(C), 136.85 (C), 136.27 (C), 130.59 (C), 128.92–127.38 (Bn-CH),
119.39 (C-6¢), 115.09 (C-5¢), 113.31 (C-2¢), 109.95 (C), 78.09 (C-
2), 77.56 (CH2), 74.31 (CH2), 71.50 (CH2), 71.42 (CH2), 68.16 (C-
3), 23.79 (C-4), 21.09 (CH3CO).
(2R,3S)-6-Acetoxy-3,5,7,3¢,4¢-penta-O-benzyl-6-hydroxy-
flavan (18)
Acetylation of 6b with py and Ac2O at r.t. for 18 h gave 18.
Yield: 17 mg (70%); colourless oil; Rf 0.44 (EtOAc–cyclohexane,
2:8).
1H NMR: d = 7.53–7.10 (m, 28 H), 7.02–6.93 (m, 5 H), 6.39 (s, 1
H, H-6), 5.21 (s, 2 H), 5.17, 5.06 (AB, J = 8.6 Hz, 2 H), 5.03 (s, 2
H), 5.02, 4.97 (AB, J = 11.0 Hz, 2 H), 4.72 (d, J = 8.0 Hz, 1 H, H-
2), 4.18, 4.02 (AB, J = 12.0 Hz, 2 H), 3.62 (m, 1 H, H-3), 3.01 (dd,
J = 16.0, 6.0 Hz, 1 H, H-4), 2.64 (dd, J = 16.0, 8.0 Hz, 1 H, H-4),
2.18 (s, 3 H, CH3CO).
13C NMR: d = 169.22 (CH3CO), 152.43 (C-8a), 150.52 (C-7),
150.00 (C-5), 149.17 (C-3¢, C-4¢), 138.00, 137.56, 137.46, 137.37,
136.76 (Bn-C), 132.33 (C-1¢), 128.62–127.29 (Bn, C-6), 120.78 (C-
6¢), 115.29 (C-5¢), 114.11 (C-2¢), 107.36 (C-4a), 97.99 (C-8), 80.47
(C-2), 75.36 (CH2), 74.47 (C-3), 71.79 (CH2), 71.61 (CH2), 71.35
(CH2), 70.93 (CH2), 26.75 (C-4), 20.51 (CH3CO).
(2R,3S)-6-Hydroxy-5,7,3¢,4¢-tetra-O-methylflavan-3-ol (14b)
MCPBA (70%, H2O; 224 mg, 0.867 mmol) was added to a solution
of (+)-tetra-O-methyl catechin21 (14a, 100 mg, 0.289 mmol) at
–10 °C. The resultant mixture was warmed to 0 °C, stirred for 3 h
and KF (106 mg, 1.82 mmol) was added. After stirring for 30 min
at r.t., the mixture was filtered and the solution was concentrated un-
der reduced pressure. The residue was purified by preparative TLC
(EtOAc–cyclohexane, 6:4) to give 21 mg (20%) of 14b.
Colourless oil; Rf 0.10 (EtOAc–cyclohexane, 6:4).
Synthesis 2006, No. 19, 3250–3260 © Thieme Stuttgart · New York